Evaluating the Effectiveness and Safety of Nerivio Device in Chronic and Episodic Migraine A Retrospective Observational Real World Evidence Analysis
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 300
- 试验地点
- 1
- 主要终点
- Demographic information of the study population
研究概览
简要总结
This study is a retrospective, observational database study intended to analyze data collected from Aug 2023 to Jul 2024 from a medical patient support program conducted for Nerivio Device users. The REN device (Nerivio) is a wearable which provides pain relief from migraine. The study duration will be of 6 months. The objective of this study is to evaluate the data and understand effectiveness of Nerivio devise in Migraine management
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 95.00 Year(s)（—）
- 性别
- All
入选标准
- •Adults diagnosed with migraine according to the International Classification of Headache Disorders, 3rd edition (ICHD-3) criteria Patients who have been prescribed and have used REN devices within the past 12 months.
排除标准
- •Patients with incomplete medical records Patients with other significant chronic pain disorders Pregnant or breastfeeding women.
结局指标
主要结局
Demographic information of the study population
时间窗: baseline to end of 12 months
Categorize and assess the types of migraines duration of migraine history and patient profiles
时间窗: baseline to end of 12 months
Proportion of patients showing improvement in clinical signs and symptoms of migraine after using Nerivio
时间窗: baseline to end of 12 months
Reduction in migraine medication regimen
时间窗: baseline to end of 12 months
次要结局
- Incidence of Adverse Event following the use of Nerivio(Baseline to 12 months)
研究者
Dr Mayank Dhore
Dr Reddys Laboratories limited